Screening older cancer patients: first evaluation of the G-8 geriatric screening tool
Development of a geriatric screening tool is necessary to identify elderly cancer patients who would benefit from comprehensive geriatric assessment (CGA). We develop and evaluate the G-8 screening tool against various reference tests. Analyses were based on 364 cancer patients aged >70 years sch...
Saved in:
| Published in | Annals of oncology Vol. 23; no. 8; pp. 2166 - 2172 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford
Elsevier Ltd
01.08.2012
Oxford University Press |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0923-7534 1569-8041 1569-8041 |
| DOI | 10.1093/annonc/mdr587 |
Cover
| Abstract | Development of a geriatric screening tool is necessary to identify elderly cancer patients who would benefit from comprehensive geriatric assessment (CGA). We develop and evaluate the G-8 screening tool against various reference tests.
Analyses were based on 364 cancer patients aged >70 years scheduled to receive first-line chemotherapy included in a multicenter prospective study. The G-8 consists of seven items from the Mini Nutritional Assessment (MNA) questionnaire and age. Our primary reference test is based on a set of seven CGA scales: Activities Daily Living (ADL), Instrumental ADL, MNA, Mini–Mental State Exam, Geriatric Depression Scale, Cumulative Illness Rating Scale-Geriatrics, and Timed Get Up and Go. We considered the presence of at least one questionnaire with an impaired score as an abnormal reference exam. Additional reference exams are also discussed.
The prevalence of being at risk varied from 60% to 94% according to the various definitions of the reference test. When considering the primary reference test, a cut-off value of 14 for the G-8 tool provided a good sensitivity estimate (85%) without deteriorating the specificity excessively (65%).
The G-8 shows good screening properties for identifying elderly cancer patients who could benefit from CGA. |
|---|---|
| AbstractList | Development of a geriatric screening tool is necessary to identify elderly cancer patients who would benefit from comprehensive geriatric assessment (CGA). We develop and evaluate the G-8 screening tool against various reference tests.BACKGROUNDDevelopment of a geriatric screening tool is necessary to identify elderly cancer patients who would benefit from comprehensive geriatric assessment (CGA). We develop and evaluate the G-8 screening tool against various reference tests.Analyses were based on 364 cancer patients aged>70 years scheduled to receive first-line chemotherapy included in a multicenter prospective study. The G-8 consists of seven items from the Mini Nutritional Assessment (MNA) questionnaire and age. Our primary reference test is based on a set of seven CGA scales: Activities Daily Living (ADL), Instrumental ADL, MNA, Mini-Mental State Exam, Geriatric Depression Scale, Cumulative Illness Rating Scale-Geriatrics, and Timed Get Up and Go. We considered the presence of at least one questionnaire with an impaired score as an abnormal reference exam. Additional reference exams are also discussed.PATIENTS AND METHODSAnalyses were based on 364 cancer patients aged>70 years scheduled to receive first-line chemotherapy included in a multicenter prospective study. The G-8 consists of seven items from the Mini Nutritional Assessment (MNA) questionnaire and age. Our primary reference test is based on a set of seven CGA scales: Activities Daily Living (ADL), Instrumental ADL, MNA, Mini-Mental State Exam, Geriatric Depression Scale, Cumulative Illness Rating Scale-Geriatrics, and Timed Get Up and Go. We considered the presence of at least one questionnaire with an impaired score as an abnormal reference exam. Additional reference exams are also discussed.The prevalence of being at risk varied from 60% to 94% according to the various definitions of the reference test. When considering the primary reference test, a cut-off value of 14 for the G-8 tool provided a good sensitivity estimate (85%) without deteriorating the specificity excessively (65%).RESULTSThe prevalence of being at risk varied from 60% to 94% according to the various definitions of the reference test. When considering the primary reference test, a cut-off value of 14 for the G-8 tool provided a good sensitivity estimate (85%) without deteriorating the specificity excessively (65%).The G-8 shows good screening properties for identifying elderly cancer patients who could benefit from CGA.CONCLUSIONThe G-8 shows good screening properties for identifying elderly cancer patients who could benefit from CGA. BACKGROUNDDevelopment of a geriatric screening tool is necessary to identify elderly cancer patients who would benefit from comprehensive geriatric assessment (CGA). We develop and evaluate the G-8 screening tool against various reference tests.PATIENTS AND METHODSAnalyses were based on 364 cancer patients aged >70 years scheduled to receive first-line chemotherapy included in a multicenter prospective study. The G-8 consists of seven items from the Mini Nutritional Assessment (MNA) questionnaire and age. Our primary reference test is based on a set of seven CGA scales: Activities Daily Living (ADL), Instrumental ADL, MNA, Mini-Mental State Exam, Geriatric Depression Scale, Cumulative Illness Rating Scale-Geriatrics, and Timed Get Up and Go. We considered the presence of at least one questionnaire with an impaired score as an abnormal reference exam. Additional reference exams are also discussed.RESULTSThe prevalence of being at risk varied from 60% to 94% according to the various definitions of the reference test. When considering the primary reference test, a cut-off value of 14 for the G-8 tool provided a good sensitivity estimate (85%) without deteriorating the specificity excessively (65%).CONCLUSIONThe G-8 shows good screening properties for identifying elderly cancer patients who could benefit from CGA. Development of a geriatric screening tool is necessary to identify elderly cancer patients who would benefit from comprehensive geriatric assessment (CGA). We develop and evaluate the G-8 screening tool against various reference tests. Analyses were based on 364 cancer patients aged>70 years scheduled to receive first-line chemotherapy included in a multicenter prospective study. The G-8 consists of seven items from the Mini Nutritional Assessment (MNA) questionnaire and age. Our primary reference test is based on a set of seven CGA scales: Activities Daily Living (ADL), Instrumental ADL, MNA, Mini-Mental State Exam, Geriatric Depression Scale, Cumulative Illness Rating Scale-Geriatrics, and Timed Get Up and Go. We considered the presence of at least one questionnaire with an impaired score as an abnormal reference exam. Additional reference exams are also discussed. The prevalence of being at risk varied from 60% to 94% according to the various definitions of the reference test. When considering the primary reference test, a cut-off value of 14 for the G-8 tool provided a good sensitivity estimate (85%) without deteriorating the specificity excessively (65%). The G-8 shows good screening properties for identifying elderly cancer patients who could benefit from CGA. Development of a geriatric screening tool is necessary to identify elderly cancer patients who would benefit from comprehensive geriatric assessment (CGA). We develop and evaluate the G-8 screening tool against various reference tests. Analyses were based on 364 cancer patients aged >70 years scheduled to receive first-line chemotherapy included in a multicenter prospective study. The G-8 consists of seven items from the Mini Nutritional Assessment (MNA) questionnaire and age. Our primary reference test is based on a set of seven CGA scales: Activities Daily Living (ADL), Instrumental ADL, MNA, Mini–Mental State Exam, Geriatric Depression Scale, Cumulative Illness Rating Scale-Geriatrics, and Timed Get Up and Go. We considered the presence of at least one questionnaire with an impaired score as an abnormal reference exam. Additional reference exams are also discussed. The prevalence of being at risk varied from 60% to 94% according to the various definitions of the reference test. When considering the primary reference test, a cut-off value of 14 for the G-8 tool provided a good sensitivity estimate (85%) without deteriorating the specificity excessively (65%). The G-8 shows good screening properties for identifying elderly cancer patients who could benefit from CGA. |
| Author | Mathoulin-Pélissier, S. Bellera, C.A. Mertens, C. Rainfray, M. Fonck, M. Delva, F. Soubeyran, P.L. |
| Author_xml | – sequence: 1 givenname: C.A. surname: Bellera fullname: Bellera, C.A. email: bellera@bergonie.org organization: Clinical Research and Clinical Epidemiology Unit, Institut Bergonié, Regional Comprehensive Cancer Centre, Bordeaux – sequence: 2 givenname: M. surname: Rainfray fullname: Rainfray, M. organization: SFR Public Health, Bordeaux University, Bordeaux – sequence: 3 givenname: S. surname: Mathoulin-Pélissier fullname: Mathoulin-Pélissier, S. organization: Clinical Research and Clinical Epidemiology Unit, Institut Bergonié, Regional Comprehensive Cancer Centre, Bordeaux – sequence: 4 givenname: C. surname: Mertens fullname: Mertens, C. organization: Department of Clinical Gerontology, Bordeaux University Hospital, Bordeaux – sequence: 5 givenname: F. surname: Delva fullname: Delva, F. organization: Clinical Research and Clinical Epidemiology Unit, Institut Bergonié, Regional Comprehensive Cancer Centre, Bordeaux – sequence: 6 givenname: M. surname: Fonck fullname: Fonck, M. organization: Department of Medical Oncology, Institut Bergonié, Regional Comprehensive Cancer Centre, Bordeaux, France – sequence: 7 givenname: P.L. surname: Soubeyran fullname: Soubeyran, P.L. organization: Department of Medical Oncology, Institut Bergonié, Regional Comprehensive Cancer Centre, Bordeaux, France |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26185575$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22250183$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUFrFTEUhYO02NenS7eSjeBm7E0ymZm4k6KtUOiidh3y7typkXnJM8kr-O8bnVcFoXR14fCdc-GcU3YUYiDG3gj4IMCoMxeqgGfbMemhf8FWQnemGaAVR2wFRqqm16o9Yac5_wCAzkjzkp1IKTWIQa3Y7Q0mouDDHY_zSImjC1jPzhVPoeSPfPIpF073bt5XLQYeJ16-E79oBn5HybuSPPL8N6bEOL9ix5ObM70-3DW7_fL52_llc3V98fX801WDbQ-lIQPYYtcLkNS2NGkFhshoJzaIEnACobB3IDsE006m1zRo2vSdczQSgVqz90vuLsWfe8rFbn1GmmcXKO6zlUoLLWU3dM-iAhRA7Uqrir49oPvNlka7S37r0i_72FoF3h0Al9HNU6qd-fyP68Sgdc1aM7VwmGLOiSaLvvwpsSTn5_rT_t7QLhvaZcPqav5zPQY_xfcLT7Xpe0_JZqzbIY0-ERY7Rv-E8wFPs7QI |
| CitedBy_id | crossref_primary_10_1016_j_ciresp_2025_01_003 crossref_primary_10_1159_000535553 crossref_primary_10_1186_s12885_018_4665_2 crossref_primary_10_1016_j_jgo_2024_101709 crossref_primary_10_3390_cancers11020250 crossref_primary_10_1016_S1470_2045_14_70018_X crossref_primary_10_1001_jamaoncol_2023_4255 crossref_primary_10_1111_ejh_13589 crossref_primary_10_1016_j_jgo_2018_09_001 crossref_primary_10_1186_s13063_020_4157_y crossref_primary_10_1200_OP_22_00668 crossref_primary_10_1016_j_jgo_2019_04_016 crossref_primary_10_1016_j_lungcan_2023_107312 crossref_primary_10_1016_j_jgo_2018_09_003 crossref_primary_10_1016_j_jgo_2018_10_007 crossref_primary_10_1016_j_jgo_2019_04_017 crossref_primary_10_1016_j_jgo_2019_12_011 crossref_primary_10_1016_j_jgo_2023_101670 crossref_primary_10_1093_jnci_djac071 crossref_primary_10_1016_j_jgo_2020_07_013 crossref_primary_10_1016_j_canrad_2015_07_154 crossref_primary_10_1093_ecco_jcc_jjae067 crossref_primary_10_3390_cancers13246154 crossref_primary_10_1007_s00268_022_06716_5 crossref_primary_10_1186_s40792_019_0610_0 crossref_primary_10_1016_j_jgo_2023_101675 crossref_primary_10_1016_j_radonc_2022_06_001 crossref_primary_10_1016_j_jgo_2024_101815 crossref_primary_10_1016_j_jgo_2023_101558 crossref_primary_10_1016_j_jgo_2024_101818 crossref_primary_10_1093_jncimonographs_lgac021 crossref_primary_10_1007_s00761_019_0588_z crossref_primary_10_1016_j_jgo_2024_101817 crossref_primary_10_1002_cpt_3339 crossref_primary_10_1093_annonc_mdt059 crossref_primary_10_1093_annonc_mdx413 crossref_primary_10_1016_j_jgo_2022_11_001 crossref_primary_10_1186_s12875_015_0241_x crossref_primary_10_1016_j_jgo_2017_07_001 crossref_primary_10_3390_jcm12020533 crossref_primary_10_1016_j_ejca_2013_06_008 crossref_primary_10_1016_j_revmed_2012_09_014 crossref_primary_10_1016_j_revmed_2012_09_016 crossref_primary_10_3390_jpm12020281 crossref_primary_10_1016_j_jgo_2017_07_008 crossref_primary_10_1097_PPO_0000000000000068 crossref_primary_10_1016_j_jgo_2023_101442 crossref_primary_10_1016_j_jgo_2023_101684 crossref_primary_10_1136_esmoopen_2015_000021 crossref_primary_10_3390_cancers13246264 crossref_primary_10_1016_j_ijrobp_2020_05_030 crossref_primary_10_1016_j_jgo_2024_101820 crossref_primary_10_1038_bjc_2017_257 crossref_primary_10_1016_j_canrad_2016_01_013 crossref_primary_10_1016_j_jgo_2023_101566 crossref_primary_10_31487_j_COR_2019_04_07 crossref_primary_10_1111_codi_13821 crossref_primary_10_1099_jmm_0_001702 crossref_primary_10_1002_hem3_69 crossref_primary_10_1016_j_jgo_2016_05_001 crossref_primary_10_1007_s00280_017_3385_7 crossref_primary_10_1007_s00432_022_04038_6 crossref_primary_10_1016_j_jgo_2021_10_007 crossref_primary_10_1080_09638288_2024_2340703 crossref_primary_10_1186_s13741_023_00299_y crossref_primary_10_1371_journal_pone_0210499 crossref_primary_10_1016_j_jamda_2021_03_025 crossref_primary_10_1007_s11888_016_0304_y crossref_primary_10_1093_nop_npad070 crossref_primary_10_3390_curroncol31120575 crossref_primary_10_1093_jnci_djs285 crossref_primary_10_1016_j_jgo_2025_102189 crossref_primary_10_1111_ggi_13781 crossref_primary_10_1016_j_jgo_2023_101450 crossref_primary_10_1007_s40266_022_00933_2 crossref_primary_10_1016_j_jgo_2021_10_001 crossref_primary_10_5106_jjshns_33_347 crossref_primary_10_1016_j_jgo_2016_05_006 crossref_primary_10_1093_annonc_mdu022 crossref_primary_10_1016_j_annder_2016_07_001 crossref_primary_10_1080_17843286_2016_1153816 crossref_primary_10_1053_j_seminoncol_2018_06_002 crossref_primary_10_1111_ecc_12302 crossref_primary_10_1016_j_jgo_2015_03_003 crossref_primary_10_3390_cancers15194845 crossref_primary_10_1159_000538733 crossref_primary_10_1016_j_jgo_2015_03_001 crossref_primary_10_4143_crt_2018_451 crossref_primary_10_1016_j_ejca_2017_06_027 crossref_primary_10_1038_bjc_2016_360 crossref_primary_10_1016_j_jgo_2021_08_006 crossref_primary_10_1016_j_radonc_2023_109862 crossref_primary_10_1002_cam4_6013 crossref_primary_10_3390_curroncol31120565 crossref_primary_10_1016_j_jgo_2018_10_018 crossref_primary_10_1016_j_ejso_2018_08_028 crossref_primary_10_1038_s41416_023_02564_9 crossref_primary_10_1016_j_jgo_2022_03_003 crossref_primary_10_1007_s00520_020_05569_9 crossref_primary_10_1016_j_jgo_2023_101584 crossref_primary_10_1200_JCO_2012_47_7430 crossref_primary_10_1007_s10549_017_4607_8 crossref_primary_10_1016_j_jgo_2023_101468 crossref_primary_10_1016_j_hpb_2024_08_007 crossref_primary_10_1016_j_jgo_2018_03_016 crossref_primary_10_1016_j_jgo_2019_05_021 crossref_primary_10_1007_s11912_021_01106_x crossref_primary_10_1016_S2666_7568_20_30060_X crossref_primary_10_1200_CCI_23_00070 crossref_primary_10_1016_j_npg_2023_05_009 crossref_primary_10_2196_59203 crossref_primary_10_1111_bjh_15622 crossref_primary_10_1007_s10388_021_00862_w crossref_primary_10_1002_cam4_6786 crossref_primary_10_1111_jdv_16607 crossref_primary_10_1007_s11864_022_00972_2 crossref_primary_10_1111_bju_16340 crossref_primary_10_1007_s00520_018_4448_y crossref_primary_10_3390_cancers15204981 crossref_primary_10_5306_wjco_v11_i3_152 crossref_primary_10_1111_jgs_15753 crossref_primary_10_1186_s12877_021_02045_9 crossref_primary_10_5534_wjmh_220280 crossref_primary_10_1093_ecco_jcc_jjad175 crossref_primary_10_1177_0956462419841478 crossref_primary_10_3389_fonc_2015_00227 crossref_primary_10_1016_j_jgo_2023_101474 crossref_primary_10_3390_curroncol29010032 crossref_primary_10_1002_cncr_34230 crossref_primary_10_1016_j_clnu_2021_02_007 crossref_primary_10_1016_j_ctrv_2020_101980 crossref_primary_10_18027_2224_5057_2022_12_1_13_20 crossref_primary_10_1007_s12603_013_0377_0 crossref_primary_10_1007_s00120_018_0704_5 crossref_primary_10_1016_j_jgo_2018_03_005 crossref_primary_10_3390_cancers16223800 crossref_primary_10_6000_1927_7229_2012_01_01_5 crossref_primary_10_1177_2333721419876126 crossref_primary_10_1016_j_jgo_2018_03_001 crossref_primary_10_1186_s13643_021_01638_0 crossref_primary_10_1097_SLA_0000000000005381 crossref_primary_10_1111_ecc_13419 crossref_primary_10_1182_blood_2017_09_746420 crossref_primary_10_3389_fonc_2022_828939 crossref_primary_10_1080_13685538_2023_2166919 crossref_primary_10_1007_s10147_014_0738_7 crossref_primary_10_3390_cancers15041002 crossref_primary_10_1007_s00408_017_9983_7 crossref_primary_10_1016_j_eururo_2018_06_008 crossref_primary_10_1016_j_semradonc_2025_02_001 crossref_primary_10_21763_tjfmpc_1222425 crossref_primary_10_1016_j_jgo_2013_08_003 crossref_primary_10_1016_j_jgo_2023_101485 crossref_primary_10_1055_s_0043_1771441 crossref_primary_10_3390_cancers14205061 crossref_primary_10_1111_1759_7714_70006 crossref_primary_10_3390_curroncol30070486 crossref_primary_10_4251_wjgo_v12_i6_604 crossref_primary_10_1016_j_yao_2022_02_011 crossref_primary_10_1016_j_cllc_2017_02_006 crossref_primary_10_2217_cpr_14_72 crossref_primary_10_1093_jjco_hyz123 crossref_primary_10_1186_s12877_018_0850_z crossref_primary_10_1016_j_jgo_2022_11_010 crossref_primary_10_1097_SPC_0000000000000635 crossref_primary_10_1080_14740338_2021_1867100 crossref_primary_10_7759_cureus_74699 crossref_primary_10_1007_s00432_022_03934_1 crossref_primary_10_1007_s00120_015_4028_4 crossref_primary_10_1007_s11523_024_01045_0 crossref_primary_10_3109_10428194_2014_953142 crossref_primary_10_1371_journal_pone_0283507 crossref_primary_10_7759_cureus_53518 crossref_primary_10_1186_s12877_023_03974_3 crossref_primary_10_1186_s12893_024_02391_6 crossref_primary_10_1016_j_dld_2022_03_001 crossref_primary_10_3390_curroncol29090484 crossref_primary_10_1007_s40266_015_0265_x crossref_primary_10_1016_j_bulcan_2014_12_011 crossref_primary_10_1007_s00129_025_05348_9 crossref_primary_10_1016_j_ejca_2021_06_006 crossref_primary_10_1002_hon_2732 crossref_primary_10_1007_s00277_023_05200_x crossref_primary_10_1186_s12885_021_08454_8 crossref_primary_10_2482_haigan_55_889 crossref_primary_10_1016_j_anl_2024_04_005 crossref_primary_10_1007_s00784_019_03056_y crossref_primary_10_1177_10781552231207839 crossref_primary_10_1016_j_jgo_2022_04_007 crossref_primary_10_1016_j_jgo_2022_04_006 crossref_primary_10_1016_j_jgo_2019_04_004 crossref_primary_10_1007_s11864_023_01071_6 crossref_primary_10_1016_j_oraloncology_2017_10_004 crossref_primary_10_1186_s12885_020_06878_2 crossref_primary_10_1016_j_ejso_2019_08_008 crossref_primary_10_7759_cureus_64533 crossref_primary_10_1136_bmjopen_2023_073126 crossref_primary_10_1016_j_jgo_2021_07_005 crossref_primary_10_1186_s12877_023_03962_7 crossref_primary_10_1016_j_oraloncology_2022_105933 crossref_primary_10_1007_s00280_014_2645_z crossref_primary_10_34175_jno202004002 crossref_primary_10_3390_jcm9082503 crossref_primary_10_1016_j_bulcan_2018_04_006 crossref_primary_10_1097_HS9_0000000000000332 crossref_primary_10_18632_oncotarget_8796 crossref_primary_10_1002_hed_27110 crossref_primary_10_1016_j_gerinurse_2015_10_004 crossref_primary_10_1016_j_gerinurse_2022_10_021 crossref_primary_10_3342_kjorl_hns_2019_00073 crossref_primary_10_1080_10428194_2024_2431563 crossref_primary_10_1016_j_oraloncology_2022_106132 crossref_primary_10_1007_s11912_016_0548_3 crossref_primary_10_1016_S1166_7087_12_70037_4 crossref_primary_10_3390_cancers14235994 crossref_primary_10_1093_jjco_hyac101 crossref_primary_10_1093_jjco_hyab137 crossref_primary_10_1016_j_ctrv_2016_09_008 crossref_primary_10_3390_jcm12247507 crossref_primary_10_1016_j_clon_2020_06_011 crossref_primary_10_1159_000531367 crossref_primary_10_3346_jkms_2020_35_e308 crossref_primary_10_1159_000520328 crossref_primary_10_3389_fonc_2021_747520 crossref_primary_10_1016_j_jgo_2019_06_017 crossref_primary_10_1016_j_critrevonc_2024_104442 crossref_primary_10_3950_jibiinkotokeibu_124_8_1179 crossref_primary_10_3143_geriatrics_59_464 crossref_primary_10_1136_bcr_2020_237031 crossref_primary_10_1080_17843286_2022_2074702 crossref_primary_10_1016_j_acuroe_2019_09_001 crossref_primary_10_1016_j_esmoop_2023_101831 crossref_primary_10_1159_000542017 crossref_primary_10_1097_MOU_0000000000001171 crossref_primary_10_1016_j_ejca_2018_03_030 crossref_primary_10_1093_jjco_hyaa152 crossref_primary_10_1016_j_jgo_2022_10_010 crossref_primary_10_1093_neuonc_nou063 crossref_primary_10_1016_j_jgo_2019_05_002 crossref_primary_10_1016_j_ejso_2024_108693 crossref_primary_10_1111_ecc_12810 crossref_primary_10_1016_j_ajoms_2024_01_011 crossref_primary_10_1182_asheducation_2016_1_425 crossref_primary_10_1016_j_otot_2020_07_003 crossref_primary_10_1007_s00405_024_08528_w crossref_primary_10_1016_j_critrevonc_2024_104533 crossref_primary_10_1016_j_jgo_2014_09_179 crossref_primary_10_3390_cancers14112809 crossref_primary_10_3390_cancers16173112 crossref_primary_10_1016_S2666_7568_21_00182_3 crossref_primary_10_3389_fonc_2022_1032471 crossref_primary_10_1016_S1877_1203_16_30036_2 crossref_primary_10_1016_j_clcc_2016_07_010 crossref_primary_10_1007_s00405_014_3017_3 crossref_primary_10_3390_cancers16142522 crossref_primary_10_1007_s12603_012_0435_z crossref_primary_10_1016_j_clinthera_2018_03_005 crossref_primary_10_1016_j_clon_2020_09_002 crossref_primary_10_1016_j_jgo_2022_01_011 crossref_primary_10_1016_j_jgo_2014_08_005 crossref_primary_10_1002_onco_13641 crossref_primary_10_1007_s00066_023_02123_4 crossref_primary_10_3390_cancers14225509 crossref_primary_10_18632_oncotarget_26147 crossref_primary_10_1007_s00432_015_2088_x crossref_primary_10_1016_j_ejon_2014_05_006 crossref_primary_10_1371_journal_pone_0115060 crossref_primary_10_1016_j_jgo_2024_102177 crossref_primary_10_1016_j_jgo_2024_102170 crossref_primary_10_3390_cancers14041072 crossref_primary_10_1007_s00455_024_10754_7 crossref_primary_10_1007_s11912_024_01558_x crossref_primary_10_1016_j_jgo_2017_02_010 crossref_primary_10_1016_S2666_7568_23_00101_0 crossref_primary_10_1016_j_ctrv_2017_03_007 crossref_primary_10_1016_j_regg_2017_10_007 crossref_primary_10_1016_j_jgo_2018_12_003 crossref_primary_10_1093_jjco_hyaa257 crossref_primary_10_1016_S2666_7568_22_00169_6 crossref_primary_10_1007_s10120_018_0834_x crossref_primary_10_1016_j_ejso_2024_109563 crossref_primary_10_3390_cancers14010244 crossref_primary_10_3390_jcm11226768 crossref_primary_10_1093_annonc_mdt386 crossref_primary_10_1016_j_jgo_2016_01_004 crossref_primary_10_1159_000531675 crossref_primary_10_1007_s13629_024_00447_z crossref_primary_10_1093_annonc_mdt269 crossref_primary_10_1186_1471_2318_14_135 crossref_primary_10_1016_j_jchirv_2015_09_008 crossref_primary_10_1038_s41598_023_44465_0 crossref_primary_10_3390_cancers10070225 crossref_primary_10_1002_jso_28068 crossref_primary_10_1002_onco_13894 crossref_primary_10_3390_cancers13071669 crossref_primary_10_3390_cancers14071634 crossref_primary_10_1245_s10434_022_12623_9 crossref_primary_10_1007_s12325_023_02460_x crossref_primary_10_1186_s12885_016_2927_4 crossref_primary_10_1007_s00520_016_3172_8 crossref_primary_10_1016_j_jgo_2024_102045 crossref_primary_10_1093_ofid_ofaa485 crossref_primary_10_1007_s13670_017_0222_0 crossref_primary_10_3390_nu15061508 crossref_primary_10_1016_j_soncn_2019_150960 crossref_primary_10_1016_j_revmed_2016_02_004 crossref_primary_10_1200_EDBK_319841 crossref_primary_10_1007_s11845_023_03446_y crossref_primary_10_3346_jkms_2020_35_e43 crossref_primary_10_4251_wjgo_v9_i1_30 crossref_primary_10_1016_j_jgo_2024_102046 crossref_primary_10_1093_jjco_hyab213 crossref_primary_10_1007_s12603_020_1420_6 crossref_primary_10_3109_0284186X_2015_1068446 crossref_primary_10_1200_EDBK_200427 crossref_primary_10_1007_s00345_013_1158_4 crossref_primary_10_1016_j_ejso_2024_108243 crossref_primary_10_3389_fmed_2024_1466366 crossref_primary_10_1182_blood_2023021564 crossref_primary_10_1016_j_jgo_2015_08_006 crossref_primary_10_1188_15_CJON_E80_E86 crossref_primary_10_5582_bst_2016_01093 crossref_primary_10_1007_s00277_023_05397_x crossref_primary_10_1111_ggi_12240 crossref_primary_10_1055_a_1982_0078 crossref_primary_10_1055_s_0044_1786392 crossref_primary_10_5630_jans_42_254 crossref_primary_10_1080_13685538_2016_1277516 crossref_primary_10_1111_bjh_19131 crossref_primary_10_1007_s11255_023_03594_1 crossref_primary_10_1016_j_purol_2019_08_279 crossref_primary_10_1002_ncp_10860 crossref_primary_10_1016_j_jviscsurg_2015_09_016 crossref_primary_10_3950_jibiinkoka_121_1079 crossref_primary_10_1007_s12603_015_0538_4 crossref_primary_10_1001_jamanetworkopen_2023_39116 crossref_primary_10_1038_s41416_021_01367_0 crossref_primary_10_1200_GO_24_00510 crossref_primary_10_1177_20101058231224488 crossref_primary_10_18632_oncotarget_17361 crossref_primary_10_1093_annonc_mdu210 crossref_primary_10_12688_wellcomeopenres_17208_1 crossref_primary_10_12688_wellcomeopenres_17208_2 crossref_primary_10_1016_j_oooo_2019_10_009 crossref_primary_10_1007_s00277_013_2001_0 crossref_primary_10_1200_JCO_23_01326 crossref_primary_10_1002_ohn_388 crossref_primary_10_1016_j_jaccao_2024_02_001 crossref_primary_10_1200_OP_23_00263 crossref_primary_10_3390_medicines8080040 crossref_primary_10_1002_cam4_4540 crossref_primary_10_1016_j_jgo_2022_02_005 crossref_primary_10_7759_cureus_58252 crossref_primary_10_1038_s41391_022_00607_5 crossref_primary_10_1002_cnr2_1613 crossref_primary_10_1007_s11912_016_0547_4 crossref_primary_10_1111_jan_16059 crossref_primary_10_1016_j_jgo_2019_06_002 crossref_primary_10_3143_geriatrics_59_472 crossref_primary_10_1016_j_jgo_2018_05_009 crossref_primary_10_1016_j_tipsro_2020_09_001 crossref_primary_10_1002_pon_3540 crossref_primary_10_1016_j_suronc_2020_04_016 crossref_primary_10_1007_s00120_015_4009_7 crossref_primary_10_1016_j_clon_2022_02_017 crossref_primary_10_1186_s12905_025_03577_7 crossref_primary_10_1016_j_dld_2016_05_011 crossref_primary_10_1055_s_0045_1806763 crossref_primary_10_1016_j_jgo_2021_09_003 crossref_primary_10_1200_JCO_23_01337 crossref_primary_10_1016_j_bulcan_2017_10_004 crossref_primary_10_1111_ecc_12509 crossref_primary_10_1186_s12894_023_01366_8 crossref_primary_10_1200_JCO_24_00117 crossref_primary_10_1016_j_jgo_2022_02_013 crossref_primary_10_15406_icpjl_2017_05_00136 crossref_primary_10_3389_fonc_2022_967421 crossref_primary_10_1159_000503901 crossref_primary_10_3389_fimmu_2024_1348034 crossref_primary_10_1200_JCO_22_01118 crossref_primary_10_5106_jjshns_33_33 crossref_primary_10_3390_dj11010006 crossref_primary_10_1007_s00345_016_1963_7 crossref_primary_10_1186_s12889_021_10433_4 crossref_primary_10_3322_caac_21864 crossref_primary_10_1007_s12603_023_1977_y crossref_primary_10_2147_CIA_S365494 crossref_primary_10_3390_cancers13040842 crossref_primary_10_1136_bmjopen_2024_089882 crossref_primary_10_1016_j_jgo_2021_05_004 crossref_primary_10_1016_j_jgo_2021_05_003 crossref_primary_10_3389_fonc_2020_00085 crossref_primary_10_1002_hed_25696 crossref_primary_10_1007_s41999_021_00510_7 crossref_primary_10_2169_internalmedicine_6760_20 crossref_primary_10_1186_s12885_023_11193_7 crossref_primary_10_1200_JCO_2012_42_9894 crossref_primary_10_1016_j_jgo_2021_05_006 crossref_primary_10_1016_S1470_2045_12_70554_5 crossref_primary_10_1016_j_jgo_2013_12_004 crossref_primary_10_1111_iju_15432 crossref_primary_10_1371_journal_pone_0138304 crossref_primary_10_34922_AE_2024_37_1_2_012 crossref_primary_10_1055_a_1525_6600 crossref_primary_10_1055_a_1695_1613 crossref_primary_10_2147_CIA_S323740 crossref_primary_10_1007_s00520_024_08834_3 crossref_primary_10_1186_s12877_020_01975_0 crossref_primary_10_4103_sja_sja_358_23 crossref_primary_10_1016_j_critrevonc_2024_104600 crossref_primary_10_1007_s13304_020_00966_5 crossref_primary_10_1200_JCO_23_00506 crossref_primary_10_3389_fonc_2023_1274264 crossref_primary_10_1007_s00280_019_03943_x crossref_primary_10_1016_j_jgo_2022_07_004 crossref_primary_10_1136_ijgc_2023_004306 crossref_primary_10_36290_xon_2018_041 crossref_primary_10_5981_jjhnc_48_261 crossref_primary_10_1016_j_jgo_2015_07_005 crossref_primary_10_1007_s00761_023_01453_3 crossref_primary_10_1016_j_ejon_2024_102591 crossref_primary_10_1007_s00432_017_2577_1 crossref_primary_10_1111_codi_15689 crossref_primary_10_1093_aje_kwx061 crossref_primary_10_1111_bjh_17384 crossref_primary_10_1016_j_ejon_2025_102827 crossref_primary_10_1016_j_annder_2015_03_022 crossref_primary_10_1159_000539261 crossref_primary_10_1016_j_urolonc_2020_01_003 crossref_primary_10_1186_s12894_019_0570_5 crossref_primary_10_1007_s00432_023_04792_1 crossref_primary_10_1016_j_jgo_2019_08_011 crossref_primary_10_1016_S1470_2045_24_00142_6 crossref_primary_10_1111_ecc_13185 crossref_primary_10_1016_j_esmoop_2024_103683 crossref_primary_10_3390_cancers13092185 crossref_primary_10_7759_cureus_46351 crossref_primary_10_1089_pmr_2023_0066 crossref_primary_10_1016_j_apjon_2024_100585 crossref_primary_10_1111_iju_15411 crossref_primary_10_1016_j_jgo_2013_04_007 crossref_primary_10_1055_a_2155_1944 crossref_primary_10_1016_j_jgo_2020_04_001 crossref_primary_10_1080_13685538_2018_1538337 crossref_primary_10_1097_CCO_0000000000000559 crossref_primary_10_3390_geriatrics7050091 crossref_primary_10_1016_j_currproblcancer_2018_01_015 crossref_primary_10_1245_s10434_024_16034_w crossref_primary_10_1007_s10147_024_02688_9 crossref_primary_10_1136_bmjopen_2023_077005 crossref_primary_10_1016_j_jgo_2018_06_013 crossref_primary_10_3390_jcm12051833 crossref_primary_10_1097_MD_0000000000036055 crossref_primary_10_1016_j_ejca_2016_09_029 crossref_primary_10_1093_annonc_mds331 crossref_primary_10_1016_j_jgo_2017_11_011 crossref_primary_10_1016_j_jgo_2021_06_004 crossref_primary_10_1093_jjco_hyac139 crossref_primary_10_1016_j_jgo_2022_08_014 crossref_primary_10_1111_den_13592 crossref_primary_10_1136_bmjopen_2021_051104 crossref_primary_10_1007_s40266_015_0312_7 crossref_primary_10_1016_j_acuro_2019_09_001 crossref_primary_10_1016_j_clon_2022_10_020 crossref_primary_10_1007_s40266_023_01034_4 crossref_primary_10_1016_j_leukres_2013_12_018 crossref_primary_10_1016_j_eurger_2015_05_008 crossref_primary_10_7889_tct_22_022 crossref_primary_10_1016_j_ctrv_2016_08_007 crossref_primary_10_1093_ced_llae067 crossref_primary_10_3390_jcm12175738 crossref_primary_10_1016_j_soncn_2015_11_007 crossref_primary_10_1111_jgs_19317 crossref_primary_10_1007_s00268_020_05886_4 crossref_primary_10_1016_j_breast_2024_103821 crossref_primary_10_1007_s11357_023_00908_0 crossref_primary_10_1007_s41999_020_00404_0 crossref_primary_10_1016_j_soncn_2015_11_004 crossref_primary_10_1016_j_ejso_2020_11_001 crossref_primary_10_1136_bmjopen_2022_071350 crossref_primary_10_1093_oncolo_oyac157 crossref_primary_10_2147_CIA_S366155 crossref_primary_10_1016_j_jgo_2019_08_005 crossref_primary_10_1093_oncolo_oyac276 crossref_primary_10_1016_j_jgo_2022_08_003 crossref_primary_10_1016_j_jgo_2019_08_007 crossref_primary_10_1016_j_jgo_2020_12_008 crossref_primary_10_1016_j_jgo_2022_08_001 crossref_primary_10_1200_JCO_22_02195 crossref_primary_10_3389_fonc_2024_1371752 crossref_primary_10_1186_s12885_018_4001_x crossref_primary_10_3390_biology12020191 crossref_primary_10_2147_NDT_S341297 crossref_primary_10_1016_S1470_2045_24_00404_2 crossref_primary_10_1016_j_clcc_2024_11_003 crossref_primary_10_1182_hematology_2019000042 crossref_primary_10_1002_cti2_1184 crossref_primary_10_1200_JCO_2012_45_6251 crossref_primary_10_1007_s00277_018_3468_5 crossref_primary_10_1080_17476348_2024_2349579 crossref_primary_10_1093_jjco_hyac013 crossref_primary_10_1055_a_1557_4972 crossref_primary_10_1007_s00405_021_07038_3 crossref_primary_10_1002_lary_27339 crossref_primary_10_1093_oncolo_oyac147 crossref_primary_10_3390_ijerph18116072 crossref_primary_10_1371_journal_pone_0264790 crossref_primary_10_1016_S2666_7568_21_00184_7 crossref_primary_10_2215_CJN_11801116 crossref_primary_10_3390_geriatrics9040101 crossref_primary_10_1007_s00432_022_04414_2 crossref_primary_10_1002_ags3_12601 crossref_primary_10_1016_j_purol_2017_07_243 crossref_primary_10_1016_j_regg_2019_10_011 crossref_primary_10_1186_s12893_022_01471_9 crossref_primary_10_1634_theoncologist_2015_0326 crossref_primary_10_1136_bmjopen_2021_054950 crossref_primary_10_1016_j_jgo_2015_10_183 crossref_primary_10_1016_S1283_081X_15_70034_2 crossref_primary_10_1200_JOP_2017_026435 crossref_primary_10_1016_j_clon_2017_05_003 crossref_primary_10_1016_j_euf_2017_10_010 crossref_primary_10_1016_j_jgo_2014_06_043 crossref_primary_10_1200_JCO_2013_51_1345 crossref_primary_10_1016_j_ejca_2017_11_013 crossref_primary_10_1007_s10147_025_02717_1 crossref_primary_10_1007_s40266_021_00889_9 crossref_primary_10_1038_bjc_2013_407 crossref_primary_10_1016_S2468_1253_22_00334_X crossref_primary_10_1200_CCI_18_00082 crossref_primary_10_1093_oncolo_oyac131 crossref_primary_10_1016_j_ejso_2024_108421 crossref_primary_10_1016_j_jgo_2019_09_010 crossref_primary_10_3390_cancers16244142 crossref_primary_10_1200_EDBK_390396 crossref_primary_10_1159_000445365 crossref_primary_10_2217_fon_2019_0019 crossref_primary_10_1186_s12885_017_3465_4 crossref_primary_10_1007_s11864_023_01167_z crossref_primary_10_1016_j_clnu_2020_03_015 crossref_primary_10_1016_S2666_7568_23_00081_8 crossref_primary_10_1016_j_oraloncology_2021_105329 crossref_primary_10_1093_oncolo_oyab034 crossref_primary_10_33590_emj_21_00262 crossref_primary_10_1186_1471_2318_14_26 crossref_primary_10_1016_j_soncn_2021_151230 crossref_primary_10_1007_s00423_021_02296_5 crossref_primary_10_1080_00015458_2019_1642598 crossref_primary_10_2217_crc_13_69 crossref_primary_10_1188_20_CJON_514_525 crossref_primary_10_1016_j_ejso_2019_08_011 crossref_primary_10_1007_s15015_023_3210_6 crossref_primary_10_1016_j_jgo_2017_09_003 crossref_primary_10_3389_fonc_2023_1124309 crossref_primary_10_1016_j_jgo_2019_09_003 crossref_primary_10_3862_jcoloproctology_74_269 crossref_primary_10_1007_s40520_023_02512_w crossref_primary_10_1016_j_jgo_2020_10_017 crossref_primary_10_1007_s00761_014_2826_8 crossref_primary_10_1097_COC_0000000000000488 crossref_primary_10_1136_bmjopen_2020_042960 crossref_primary_10_1177_19160216241248666 crossref_primary_10_3389_fonc_2024_1391464 crossref_primary_10_1182_hematology_2020000099 crossref_primary_10_1016_j_jgo_2014_04_004 crossref_primary_10_1093_oncolo_oyab020 crossref_primary_10_4274_uob_galenos_2022_2022_2_1 crossref_primary_10_1016_j_jtocrr_2022_100353 crossref_primary_10_1186_s12877_021_02544_9 crossref_primary_10_4111_icu_2019_60_4_235 crossref_primary_10_1016_j_jgo_2013_09_121 crossref_primary_10_1016_j_jgo_2021_03_008 crossref_primary_10_1007_s11912_016_0551_8 crossref_primary_10_1007_s11912_024_01629_z crossref_primary_10_1093_jnci_djz189 crossref_primary_10_3390_cancers15061674 crossref_primary_10_1007_s00277_018_3420_8 crossref_primary_10_1016_S2468_1253_19_30041_X crossref_primary_10_1016_S2666_7568_23_00209_X crossref_primary_10_3389_fonc_2022_904644 crossref_primary_10_1016_j_bj_2021_03_002 crossref_primary_10_1016_j_jgo_2020_10_013 crossref_primary_10_1016_j_jgo_2023_101604 crossref_primary_10_1016_j_ejcsup_2016_01_001 crossref_primary_10_1007_s00405_024_08651_8 crossref_primary_10_1007_s13670_017_0218_9 crossref_primary_10_1016_j_soncn_2017_08_006 crossref_primary_10_1093_ageing_afaf008 crossref_primary_10_1016_j_jgo_2023_101606 crossref_primary_10_3950_jibiinkoka_121_946 crossref_primary_10_1016_j_jgo_2020_10_007 crossref_primary_10_1016_j_jgo_2016_07_011 crossref_primary_10_1016_j_oraloncology_2020_105020 crossref_primary_10_1007_s00423_016_1388_1 crossref_primary_10_1016_j_bulcan_2016_08_004 crossref_primary_10_14283_jfa_2021_2 crossref_primary_10_1016_j_jgo_2024_101770 crossref_primary_10_1186_s12885_023_10807_4 crossref_primary_10_1016_j_semradonc_2021_11_010 crossref_primary_10_1200_OP_21_00513 crossref_primary_10_1093_bjsopen_zrad053 crossref_primary_10_1586_14737140_2016_1170595 crossref_primary_10_1016_j_jgo_2024_101778 crossref_primary_10_1016_j_revmed_2021_10_006 crossref_primary_10_1016_j_jgo_2024_101776 crossref_primary_10_1111_ecc_13357 crossref_primary_10_1016_j_jgo_2021_12_009 crossref_primary_10_1016_S2666_7568_24_00118_1 crossref_primary_10_1111_jgs_18023 crossref_primary_10_1097_CCO_0000000000001006 crossref_primary_10_1016_j_archger_2019_02_008 crossref_primary_10_1200_JCO_2018_78_8687 crossref_primary_10_2490_jjrmc_61_718 crossref_primary_10_1007_s11701_021_01301_9 crossref_primary_10_1111_iju_14839 crossref_primary_10_1055_a_1224_2390 crossref_primary_10_1016_j_jviscsurg_2015_06_004 crossref_primary_10_1016_j_jgo_2023_101502 crossref_primary_10_1016_j_jgo_2023_101500 crossref_primary_10_3390_cancers16030558 crossref_primary_10_1016_j_jgo_2023_101506 crossref_primary_10_1186_1472_6947_13_93 crossref_primary_10_1016_j_suronc_2020_08_014 crossref_primary_10_1186_s12885_017_3445_8 crossref_primary_10_1007_s00277_018_3551_y crossref_primary_10_1200_JCO_23_00930 crossref_primary_10_1200_JCO_23_00933 crossref_primary_10_1093_annonc_mds619 crossref_primary_10_1186_s12873_016_0087_0 crossref_primary_10_15766_mep_2374_8265_11471 crossref_primary_10_1093_jnci_djaf017 crossref_primary_10_4103_jrcr_jrcr_38_24 crossref_primary_10_1001_jamaoncol_2020_6736 crossref_primary_10_1016_j_heliyon_2024_e30723 crossref_primary_10_3390_ph14030233 crossref_primary_10_5981_jjhnc_48_28 crossref_primary_10_1016_j_clnu_2016_12_003 crossref_primary_10_1097_HS9_0000000000000808 crossref_primary_10_5981_jjhnc_47_376 crossref_primary_10_1007_s00404_022_06850_4 crossref_primary_10_1093_ageing_afae222 crossref_primary_10_5106_jjshns_33_205 crossref_primary_10_1007_s00345_021_03632_6 crossref_primary_10_1016_j_jchirv_2014_10_013 crossref_primary_10_1016_j_jgo_2023_101631 crossref_primary_10_1016_j_scrs_2024_101064 crossref_primary_10_3390_jcm12103445 crossref_primary_10_1001_jamanetworkopen_2021_14694 crossref_primary_10_1007_s12612_012_0306_6 crossref_primary_10_1016_j_jgo_2022_12_005 crossref_primary_10_1016_j_jgo_2017_08_009 crossref_primary_10_3390_cancers15051553 crossref_primary_10_1016_j_jgo_2024_101739 crossref_primary_10_1016_j_pulmoe_2018_07_004 crossref_primary_10_1016_j_cger_2018_01_003 crossref_primary_10_1371_journal_pone_0179694 crossref_primary_10_3889_oamjms_2022_9709 crossref_primary_10_36290_xon_2020_007 crossref_primary_10_1016_j_ejca_2022_06_043 crossref_primary_10_3390_jcm13010212 crossref_primary_10_1007_s12603_016_0677_2 crossref_primary_10_2478_fco_2023_0026 crossref_primary_10_1093_jnci_djae163 crossref_primary_10_1016_j_euo_2024_02_009 crossref_primary_10_1016_j_ijrobp_2017_01_211 crossref_primary_10_1634_theoncologist_2014_0180 crossref_primary_10_1093_annonc_mdx068 crossref_primary_10_1080_1120009X_2018_1475442 crossref_primary_10_1186_s12885_024_12653_4 crossref_primary_10_3389_fonc_2024_1325610 crossref_primary_10_3390_geriatrics7050107 crossref_primary_10_1016_j_jgo_2024_101743 crossref_primary_10_1016_j_jgo_2024_101742 crossref_primary_10_1016_j_jgo_2023_101528 crossref_primary_10_1111_ecc_12179 crossref_primary_10_1016_j_jgo_2023_101647 crossref_primary_10_1016_j_ejca_2016_11_003 crossref_primary_10_1186_s12885_020_6526_z crossref_primary_10_1200_JCO_20_00714 crossref_primary_10_1007_s15004_016_5205_3 crossref_primary_10_3389_fonc_2023_1110236 crossref_primary_10_1186_s12885_023_11035_6 crossref_primary_10_1080_14737140_2020_1744439 crossref_primary_10_2217_fon_2019_0786 crossref_primary_10_1155_2017_1695101 crossref_primary_10_1200_OP_22_00842 crossref_primary_10_1097_TIN_0000000000000381 crossref_primary_10_1007_s00092_015_0476_9 crossref_primary_10_1093_dote_doae096 crossref_primary_10_1016_j_jgo_2020_03_010 crossref_primary_10_1016_S1470_2045_24_00507_2 crossref_primary_10_3390_medicines10100056 crossref_primary_10_1016_j_jgo_2023_101656 crossref_primary_10_1002_cncr_31581 crossref_primary_10_1016_j_jgo_2020_03_017 crossref_primary_10_1016_j_jgo_2024_101713 crossref_primary_10_1016_j_ejso_2019_12_001 crossref_primary_10_1016_j_ejca_2022_12_012 crossref_primary_10_1007_s10147_023_02296_z crossref_primary_10_1016_j_ctrv_2024_102853 crossref_primary_10_1016_j_jgo_2024_101838 crossref_primary_10_1182_blood_2017_09_806398 crossref_primary_10_1200_EDBK_158668 crossref_primary_10_1080_0284186X_2022_2036366 crossref_primary_10_1007_s11605_022_05513_8 crossref_primary_10_1111_bjd_20833 crossref_primary_10_1016_j_exger_2019_110787 crossref_primary_10_1186_s12885_015_1800_1 crossref_primary_10_1016_j_jgo_2020_03_009 crossref_primary_10_1186_s13063_017_1894_7 crossref_primary_10_1016_j_esmoop_2024_103657 crossref_primary_10_1097_MOU_0000000000000501 crossref_primary_10_1002_jso_27206 crossref_primary_10_3390_cancers13133363 crossref_primary_10_3390_cancers14061386 crossref_primary_10_1016_j_jgo_2023_101425 crossref_primary_10_1038_s41391_017_0020_y crossref_primary_10_1016_j_ophtha_2015_07_009 crossref_primary_10_1093_jjco_hyae015 |
| Cites_doi | 10.1111/j.1532-5415.1968.tb02103.x 10.1200/JCO.2007.10.6559 10.1111/j.1532-5415.1991.tb02700.x 10.1200/JCO.2010.31.0664 10.1093/geront/37.2.182 10.1200/JCO.2009.25.9978 10.1016/j.critrevonc.2009.12.002 10.1016/S0140-6736(98)04402-X 10.1300/J018v05n01_09 10.1111/j.1532-5415.1992.tb01802.x 10.1111/j.1532-5415.1995.tb07192.x 10.1136/bmj.d6553 10.1016/0022-3956(75)90026-6 10.1093/gerona/56.6.M366 10.1016/0140-6736(93)92884-V 10.1002/cncr.22495 10.1111/j.1468-1331.2009.02783.x 10.7326/0003-4819-112-9-699 10.1200/JCO.2005.02.527 10.1200/JCO.2006.06.4451 10.1200/jco.2007.25.18_suppl.9040 10.1200/JCO.2010.32.0796 10.1056/NEJM198412273112604 10.1016/S0959-8049(03)00662-2 10.1046/j.1532-5415.2001.49281.x 10.1111/j.1532-5415.1991.tb01616.x 10.7326/0003-4819-138-1-200301070-00010 10.1016/j.critrevonc.2010.06.004 10.1016/j.critrevonc.2005.06.003 10.1001/jama.1963.03060120024016 10.1200/JCO.2011.36.3911 10.1093/geront/9.3_Part_1.179 10.1016/S1040-8428(09)70042-3 10.1093/gerona/63.3.298 |
| ContentType | Journal Article |
| Copyright | 2012 European Society for Medical Oncology 2015 INIST-CNRS |
| Copyright_xml | – notice: 2012 European Society for Medical Oncology – notice: 2015 INIST-CNRS |
| DBID | 6I. AAFTH AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1093/annonc/mdr587 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1569-8041 |
| EndPage | 2172 |
| ExternalDocumentID | 22250183 26185575 10_1093_annonc_mdr587 S0923753419381025 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6I. 6J9 70D AABJS AABMN AAEDW AAESY AAFTH AAIAV AAIYJ AAJKP AAJQQ AAKAS AAKUH AAMVS AAOGV AAPNW AAUQX AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACIMA ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEIU ADEYI ADHKW ADHZD ADJQC ADOCK ADORX ADQLU ADRIX ADRTK ADYVW ADZCM ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFIYH AFOFC AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AIKOY AITUG ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASMCH ASPBG ATTQO AVWKF AWCFO AXUDD AZFZN AZQFJ BAWUL BAYMD BEYMZ BGNMA BGYMP BHONS BTRTY BVRKM BZKNY C1A CAG CASEJ CDBKE CKLRP COF CS3 CZ4 DAKXR DIK DILTD DL5 DPORF DPPUQ D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KC5 KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 AAGQS AALRI AAYWO AAYXX ABNGD ACUKT ACVFH ADCNI ADVLN AEHUL AEUPX AFETI AFJKZ AFPUW AFSHK AGCQF AGQPQ AIGII AKBMS AKRWK AKYEP APXCP CITATION H13 EFKBS IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c470t-e90c4c67102e44ef5309ee95a1bcc20cf013c7a026c094f975e85eb76aaedee03 |
| ISSN | 0923-7534 1569-8041 |
| IngestDate | Thu Sep 04 16:42:15 EDT 2025 Thu Sep 04 17:10:45 EDT 2025 Wed Feb 19 02:03:05 EST 2025 Mon Jul 21 09:14:46 EDT 2025 Thu Apr 24 22:55:29 EDT 2025 Tue Jul 01 02:10:09 EDT 2025 Fri Feb 23 02:46:09 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | screening cancer elderly sensitivity and specificity Human Screening Evaluation Sensitivity Specificity Malignant tumor Medical screening Elderly Cancer Geriatrics Primary cancer |
| Language | English |
| License | http://www.elsevier.com/open-access/userlicense/1.0 https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c470t-e90c4c67102e44ef5309ee95a1bcc20cf013c7a026c094f975e85eb76aaedee03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://dx.doi.org/10.1093/annonc/mdr587 |
| PMID | 22250183 |
| PQID | 1030075353 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_2351522686 proquest_miscellaneous_1030075353 pubmed_primary_22250183 pascalfrancis_primary_26185575 crossref_citationtrail_10_1093_annonc_mdr587 crossref_primary_10_1093_annonc_mdr587 elsevier_sciencedirect_doi_10_1093_annonc_mdr587 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2012-08-01 |
| PublicationDateYYYYMMDD | 2012-08-01 |
| PublicationDate_xml | – month: 08 year: 2012 text: 2012-08-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford |
| PublicationPlace_xml | – name: Oxford – name: England |
| PublicationTitle | Annals of oncology |
| PublicationTitleAlternate | Ann Oncol |
| PublicationYear | 2012 |
| Publisher | Elsevier Ltd Oxford University Press |
| Publisher_xml | – name: Elsevier Ltd – name: Oxford University Press |
| References | Balducci, Yates (bb0055) 2000; 14 Ellis, Whitehead, Robinson (bb0010) 2011; 343 Luciani, Ascione, Bertuzzi (bb0115) 2010; 28 Brody, Johnson, Douglas (bb0085) 1997; 37 Mohile, Bylow, Dale (bb0100) 2007; 109 Molina-Garrido, Guillen-Ponce (bb0110) 2011; 79 Linn, Linn, Gurel (bb0180) 1968; 16 ALucianiIFlorianiPFoaReply to C. Falci et alJ Clin Oncol 2010 Aug 16. [Epub ahead of print] Huss, Stuck, Rubenstein (bb0015) 2008; 63 Miller, Towers (bb0185) 1991 Katz, Ford, Moskowitz (bb0140) 1963; 185 Sheikh, Yesavage (bb0155) 1986; 5 Rubenstein, Josephson, Wieland (bb0020) 1984; 311 Yesavage (bb0160) 1988; 24 Caillet, Canoui-Poitrine, Vouriot (bb0035) 2011; 29 Gill, Williams, Tinetti (bb0080) 1995; 43 Stuck, Siu, Wieland (bb0025) 1993; 342 Mura, Dartigues, Berr (bb0200) 2010; 17 Barberger-Gateau, Commenges, Gagnon (bb0195) 1992; 40 Soubeyran, Rainfray, Mathoulin-Pelissier (bb0135) 2007 Smith, Khatcheressian, Lyman (bb0065) 2006; 24 Molina-Garrido, Guillen-Ponce (bb0125) 2011; 29 Extermann, Hurria (bb0045) 2007; 25 Lawton, Brody (bb0145) 1969; 9 Extermann, Aapro, Bernabei (bb0050) 2005; 55 Rubenstein, Harker, Salva (bb0190) 2001; 56 Lachs, Feinstein, Cooney (bb0070) 1990; 112 Kellen, Bulens, Deckx (bb0105) 2010; 75 Bossuyt, Reitsma, Bruns (bb0130) 2003; 138 Podsiadlo, Richardson (bb0175) 1991; 39 Rockwood, Stadnyk, MacKnight (bb0090) 1999; 353 Folstein, Folstein, McHugh (bb0150) 1975; 12 Falci, Basso, Fiduccia (bb0120) 2009; 72 Kanesvaran, Li, Koo (bb0040) 2011; 29 Maione, Perrone, Gallo (bb0030) 2005; 23 Winograd, Gerety, Chung (bb0075) 1991; 39 Repetto, Biganzoli, Koehne (bb0060) 2003; 39 Guigoz, Vellas, Garry (bb0165) 1994; 4 Mathias, Nayak, Isaacs (bb0170) 1986; 67 Saliba, Elliott, Rubenstein (bb0095) 2001; 49 Stuck (10.1093/annonc/mdr587_bb0025) 1993; 342 Brody (10.1093/annonc/mdr587_bb0085) 1997; 37 Yesavage (10.1093/annonc/mdr587_bb0160) 1988; 24 Balducci (10.1093/annonc/mdr587_bb0055) 2000; 14 Molina-Garrido (10.1093/annonc/mdr587_bb0125) 2011; 29 Gill (10.1093/annonc/mdr587_bb0080) 1995; 43 Maione (10.1093/annonc/mdr587_bb0030) 2005; 23 Smith (10.1093/annonc/mdr587_bb0065) 2006; 24 Mohile (10.1093/annonc/mdr587_bb0100) 2007; 109 Barberger-Gateau (10.1093/annonc/mdr587_bb0195) 1992; 40 Miller (10.1093/annonc/mdr587_bb0185) 1991 Huss (10.1093/annonc/mdr587_bb0015) 2008; 63 Kanesvaran (10.1093/annonc/mdr587_bb0040) 2011; 29 Molina-Garrido (10.1093/annonc/mdr587_bb0110) 2011; 79 Extermann (10.1093/annonc/mdr587_bb0045) 2007; 25 Katz (10.1093/annonc/mdr587_bb0140) 1963; 185 Podsiadlo (10.1093/annonc/mdr587_bb0175) 1991; 39 Kellen (10.1093/annonc/mdr587_bb0105) 2010; 75 Rubenstein (10.1093/annonc/mdr587_bb0190) 2001; 56 Ellis (10.1093/annonc/mdr587_bb0010) 2011; 343 10.1093/annonc/mdr587_bb0205 Mathias (10.1093/annonc/mdr587_bb0170) 1986; 67 Saliba (10.1093/annonc/mdr587_bb0095) 2001; 49 Repetto (10.1093/annonc/mdr587_bb0060) 2003; 39 Luciani (10.1093/annonc/mdr587_bb0115) 2010; 28 Falci (10.1093/annonc/mdr587_bb0120) 2009; 72 Bossuyt (10.1093/annonc/mdr587_bb0130) 2003; 138 Winograd (10.1093/annonc/mdr587_bb0075) 1991; 39 Sheikh (10.1093/annonc/mdr587_bb0155) 1986; 5 Extermann (10.1093/annonc/mdr587_bb0050) 2005; 55 Guigoz (10.1093/annonc/mdr587_bb0165) 1994; 4 Linn (10.1093/annonc/mdr587_bb0180) 1968; 16 Caillet (10.1093/annonc/mdr587_bb0035) 2011; 29 Rockwood (10.1093/annonc/mdr587_bb0090) 1999; 353 Rubenstein (10.1093/annonc/mdr587_bb0020) 1984; 311 Lawton (10.1093/annonc/mdr587_bb0145) 1969; 9 Soubeyran (10.1093/annonc/mdr587_bb0135) 2007 Mura (10.1093/annonc/mdr587_bb0200) 2010; 17 Lachs (10.1093/annonc/mdr587_bb0070) 1990; 112 Folstein (10.1093/annonc/mdr587_bb0150) 1975; 12 |
| References_xml | – volume: 4 start-page: 15 year: 1994 end-page: 59 ident: bb0165 article-title: Mini nutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients publication-title: Facts Res Gerontol – volume: 25 start-page: 1824 year: 2007 end-page: 1831 ident: bb0045 article-title: Comprehensive geriatric assessment for older patients with cancer publication-title: J Clin Oncol – volume: 28 start-page: 2046 year: 2010 end-page: 2050 ident: bb0115 article-title: Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13 publication-title: J Clin Oncol – year: 1991 ident: bb0185 article-title: A Manual of Guidelines for Scoring the Cumulative Illness Rating Scale for Geriatrics (CIRS-G) – volume: 353 start-page: 205 year: 1999 end-page: 206 ident: bb0090 article-title: A brief clinical instrument to classify frailty in elderly people publication-title: Lancet – volume: 39 start-page: 2264 year: 2003 end-page: 2272 ident: bb0060 article-title: EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer publication-title: Eur J Cancer – volume: 9 start-page: 179 year: 1969 end-page: 186 ident: bb0145 article-title: Assessment of older people: self-maintaining and instrumental activities of daily living publication-title: Gerontologist – volume: 24 start-page: 3187 year: 2006 end-page: 3205 ident: bb0065 article-title: 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline publication-title: J Clin Oncol – volume: 39 start-page: 778 year: 1991 end-page: 784 ident: bb0075 article-title: Screening for frailty: criteria and predictors of outcomes publication-title: J Am Geriatr Soc – volume: 37 start-page: 182 year: 1997 end-page: 191 ident: bb0085 article-title: Evaluation of a self-report screening instrument to predict frailty outcomes in aging populations publication-title: Gerontologist – volume: 12 start-page: 189 year: 1975 end-page: 198 ident: bb0150 article-title: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician publication-title: J Psychiatr Res – volume: 17 start-page: 252 year: 2010 end-page: 259 ident: bb0200 article-title: How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050 publication-title: Eur J Neurol – volume: 109 start-page: 802 year: 2007 end-page: 810 ident: bb0100 article-title: A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation publication-title: Cancer – volume: 79 start-page: 51 year: 2011 end-page: 64 ident: bb0110 article-title: Comparison of two frailty screening tools in older women with early breast cancer publication-title: Crit Rev Oncol Hematol – volume: 63 start-page: 298 year: 2008 end-page: 307 ident: bb0015 article-title: Multidimensional preventive home visit programs for community-dwelling older adults: a systematic review and meta-analysis of randomized controlled trials publication-title: J Gerontol A Biol Sci Med Sci – volume: 138 start-page: 40 year: 2003 end-page: 44 ident: bb0130 article-title: Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative publication-title: Ann Intern Med – volume: 39 start-page: 142 year: 1991 end-page: 148 ident: bb0175 article-title: The timed “Up & Go”: a test of basic functional mobility for frail elderly persons publication-title: J Am Geriatr Soc – volume: 75 start-page: 243 year: 2010 end-page: 248 ident: bb0105 article-title: Identifying an accurate pre-screening tool in geriatric oncology publication-title: Crit Rev Oncol Hematol – volume: 24 start-page: 709 year: 1988 end-page: 711 ident: bb0160 article-title: Geriatric Depression Scale publication-title: Psychopharmacol Bull – volume: 49 start-page: 1691 year: 2001 end-page: 1699 ident: bb0095 article-title: The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community publication-title: J Am Geriatr Soc – volume: 29 start-page: 3201 year: 2011 end-page: 3202 ident: bb0125 article-title: Overvaluation of the vulnerable elders survey-13 as a screening tool for vulnerability publication-title: J Clin Oncol – year: 2007 ident: bb0135 article-title: Prediction of early death risk in the elderly with cancer: results of a prospective multicentric study of 364 patients under chemotherapy publication-title: J Clin Oncol – volume: 112 start-page: 699 year: 1990 end-page: 706 ident: bb0070 article-title: A simple procedure for general screening for functional disability in elderly patients publication-title: Ann Intern Med – volume: 43 start-page: 603 year: 1995 end-page: 609 ident: bb0080 article-title: Assessing risk for the onset of functional dependence among older adults: the role of physical performance publication-title: J Am Geriatr Soc – reference: ALucianiIFlorianiPFoaReply to C. Falci et alJ Clin Oncol 2010 Aug 16. [Epub ahead of print] – volume: 56 start-page: M366 year: 2001 end-page: M372 ident: bb0190 article-title: Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF) publication-title: J Gerontol A Biol Sci Med Sci – volume: 14 start-page: 221 year: 2000 end-page: 227 ident: bb0055 article-title: General guidelines for the management of older patients with cancer publication-title: Oncology (Williston Park) – volume: 29 start-page: 3620 year: 2011 end-page: 3627 ident: bb0040 article-title: Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer publication-title: J Clin Oncol – volume: 55 start-page: 241 year: 2005 end-page: 252 ident: bb0050 article-title: Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG) publication-title: Crit Rev Oncol Hematol – volume: 343 start-page: d6553 year: 2011 ident: bb0010 article-title: Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials publication-title: BMJ – volume: 23 start-page: 6865 year: 2005 end-page: 6872 ident: bb0030 article-title: Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study publication-title: J Clin Oncol – volume: 311 start-page: 1664 year: 1984 end-page: 1670 ident: bb0020 article-title: Effectiveness of a geriatric evaluation unit. A randomized clinical trial publication-title: N Engl J Med – volume: 67 start-page: 387 year: 1986 end-page: 389 ident: bb0170 article-title: Balance in elderly patients: the “get-up and go” test publication-title: Arch Phys Med Rehabil – volume: 40 start-page: 1129 year: 1992 end-page: 1134 ident: bb0195 article-title: Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers publication-title: J Am Geriatr Soc – volume: 29 start-page: 3636 year: 2011 end-page: 3642 ident: bb0035 article-title: Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA Study publication-title: J Clin Oncol – volume: 185 start-page: 914 year: 1963 end-page: 919 ident: bb0140 article-title: Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function publication-title: JAMA – volume: 16 start-page: 622 year: 1968 end-page: 626 ident: bb0180 article-title: Cumulative illness rating scale publication-title: J Am Geriatr Soc – volume: 72 start-page: 19 year: 2009 end-page: 20 ident: bb0120 article-title: Is vulnerable elders survey 13 (VES-13) a sensitive and specific screening tool for identifying vulnerable/frail elderly cancer patients compared to full comprehensive geriatric assessment (CGA)? publication-title: Crit Rev Oncol Hematol – volume: 5 start-page: 165 year: 1986 end-page: 171 ident: bb0155 article-title: Geriatric Depression Scale (GDS). Recent evidence and development of a shorter version publication-title: Clin Gerontol – volume: 342 start-page: 1032 year: 1993 end-page: 1036 ident: bb0025 article-title: Comprehensive geriatric assessment: a meta-analysis of controlled trials publication-title: Lancet – volume: 67 start-page: 387 year: 1986 ident: 10.1093/annonc/mdr587_bb0170 article-title: Balance in elderly patients: the “get-up and go” test publication-title: Arch Phys Med Rehabil – volume: 16 start-page: 622 year: 1968 ident: 10.1093/annonc/mdr587_bb0180 article-title: Cumulative illness rating scale publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.1968.tb02103.x – volume: 25 start-page: 1824 year: 2007 ident: 10.1093/annonc/mdr587_bb0045 article-title: Comprehensive geriatric assessment for older patients with cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2007.10.6559 – volume: 39 start-page: 778 year: 1991 ident: 10.1093/annonc/mdr587_bb0075 article-title: Screening for frailty: criteria and predictors of outcomes publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.1991.tb02700.x – volume: 29 start-page: 3636 year: 2011 ident: 10.1093/annonc/mdr587_bb0035 article-title: Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA Study publication-title: J Clin Oncol doi: 10.1200/JCO.2010.31.0664 – volume: 37 start-page: 182 year: 1997 ident: 10.1093/annonc/mdr587_bb0085 article-title: Evaluation of a self-report screening instrument to predict frailty outcomes in aging populations publication-title: Gerontologist doi: 10.1093/geront/37.2.182 – volume: 28 start-page: 2046 year: 2010 ident: 10.1093/annonc/mdr587_bb0115 article-title: Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.25.9978 – volume: 75 start-page: 243 year: 2010 ident: 10.1093/annonc/mdr587_bb0105 article-title: Identifying an accurate pre-screening tool in geriatric oncology publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2009.12.002 – volume: 353 start-page: 205 year: 1999 ident: 10.1093/annonc/mdr587_bb0090 article-title: A brief clinical instrument to classify frailty in elderly people publication-title: Lancet doi: 10.1016/S0140-6736(98)04402-X – volume: 5 start-page: 165 year: 1986 ident: 10.1093/annonc/mdr587_bb0155 article-title: Geriatric Depression Scale (GDS). Recent evidence and development of a shorter version publication-title: Clin Gerontol doi: 10.1300/J018v05n01_09 – volume: 40 start-page: 1129 year: 1992 ident: 10.1093/annonc/mdr587_bb0195 article-title: Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.1992.tb01802.x – volume: 43 start-page: 603 year: 1995 ident: 10.1093/annonc/mdr587_bb0080 article-title: Assessing risk for the onset of functional dependence among older adults: the role of physical performance publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.1995.tb07192.x – volume: 343 start-page: d6553 year: 2011 ident: 10.1093/annonc/mdr587_bb0010 article-title: Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials publication-title: BMJ doi: 10.1136/bmj.d6553 – volume: 14 start-page: 221 year: 2000 ident: 10.1093/annonc/mdr587_bb0055 article-title: General guidelines for the management of older patients with cancer publication-title: Oncology (Williston Park) – volume: 12 start-page: 189 year: 1975 ident: 10.1093/annonc/mdr587_bb0150 article-title: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician publication-title: J Psychiatr Res doi: 10.1016/0022-3956(75)90026-6 – volume: 56 start-page: M366 year: 2001 ident: 10.1093/annonc/mdr587_bb0190 article-title: Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF) publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/56.6.M366 – volume: 342 start-page: 1032 year: 1993 ident: 10.1093/annonc/mdr587_bb0025 article-title: Comprehensive geriatric assessment: a meta-analysis of controlled trials publication-title: Lancet doi: 10.1016/0140-6736(93)92884-V – volume: 109 start-page: 802 year: 2007 ident: 10.1093/annonc/mdr587_bb0100 article-title: A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation publication-title: Cancer doi: 10.1002/cncr.22495 – volume: 17 start-page: 252 year: 2010 ident: 10.1093/annonc/mdr587_bb0200 article-title: How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050 publication-title: Eur J Neurol doi: 10.1111/j.1468-1331.2009.02783.x – volume: 112 start-page: 699 year: 1990 ident: 10.1093/annonc/mdr587_bb0070 article-title: A simple procedure for general screening for functional disability in elderly patients publication-title: Ann Intern Med doi: 10.7326/0003-4819-112-9-699 – volume: 23 start-page: 6865 year: 2005 ident: 10.1093/annonc/mdr587_bb0030 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.02.527 – volume: 24 start-page: 709 year: 1988 ident: 10.1093/annonc/mdr587_bb0160 article-title: Geriatric Depression Scale publication-title: Psychopharmacol Bull – volume: 4 start-page: 15 issue: Suppl 2 year: 1994 ident: 10.1093/annonc/mdr587_bb0165 article-title: Mini nutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients publication-title: Facts Res Gerontol – volume: 24 start-page: 3187 year: 2006 ident: 10.1093/annonc/mdr587_bb0065 article-title: 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline publication-title: J Clin Oncol doi: 10.1200/JCO.2006.06.4451 – year: 2007 ident: 10.1093/annonc/mdr587_bb0135 article-title: Prediction of early death risk in the elderly with cancer: results of a prospective multicentric study of 364 patients under chemotherapy publication-title: J Clin Oncol doi: 10.1200/jco.2007.25.18_suppl.9040 – volume: 29 start-page: 3620 year: 2011 ident: 10.1093/annonc/mdr587_bb0040 article-title: Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2010.32.0796 – volume: 311 start-page: 1664 year: 1984 ident: 10.1093/annonc/mdr587_bb0020 article-title: Effectiveness of a geriatric evaluation unit. A randomized clinical trial publication-title: N Engl J Med doi: 10.1056/NEJM198412273112604 – volume: 39 start-page: 2264 year: 2003 ident: 10.1093/annonc/mdr587_bb0060 article-title: EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer publication-title: Eur J Cancer doi: 10.1016/S0959-8049(03)00662-2 – ident: 10.1093/annonc/mdr587_bb0205 – volume: 49 start-page: 1691 year: 2001 ident: 10.1093/annonc/mdr587_bb0095 article-title: The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community publication-title: J Am Geriatr Soc doi: 10.1046/j.1532-5415.2001.49281.x – volume: 39 start-page: 142 year: 1991 ident: 10.1093/annonc/mdr587_bb0175 article-title: The timed “Up & Go”: a test of basic functional mobility for frail elderly persons publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.1991.tb01616.x – volume: 138 start-page: 40 year: 2003 ident: 10.1093/annonc/mdr587_bb0130 article-title: Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative publication-title: Ann Intern Med doi: 10.7326/0003-4819-138-1-200301070-00010 – year: 1991 ident: 10.1093/annonc/mdr587_bb0185 – volume: 79 start-page: 51 year: 2011 ident: 10.1093/annonc/mdr587_bb0110 article-title: Comparison of two frailty screening tools in older women with early breast cancer publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2010.06.004 – volume: 55 start-page: 241 year: 2005 ident: 10.1093/annonc/mdr587_bb0050 article-title: Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG) publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2005.06.003 – volume: 185 start-page: 914 year: 1963 ident: 10.1093/annonc/mdr587_bb0140 article-title: Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function publication-title: JAMA doi: 10.1001/jama.1963.03060120024016 – volume: 29 start-page: 3201 issue: 23 year: 2011 ident: 10.1093/annonc/mdr587_bb0125 article-title: Overvaluation of the vulnerable elders survey-13 as a screening tool for vulnerability publication-title: J Clin Oncol doi: 10.1200/JCO.2011.36.3911 – volume: 9 start-page: 179 year: 1969 ident: 10.1093/annonc/mdr587_bb0145 article-title: Assessment of older people: self-maintaining and instrumental activities of daily living publication-title: Gerontologist doi: 10.1093/geront/9.3_Part_1.179 – volume: 72 start-page: 19 year: 2009 ident: 10.1093/annonc/mdr587_bb0120 article-title: Is vulnerable elders survey 13 (VES-13) a sensitive and specific screening tool for identifying vulnerable/frail elderly cancer patients compared to full comprehensive geriatric assessment (CGA)? publication-title: Crit Rev Oncol Hematol doi: 10.1016/S1040-8428(09)70042-3 – volume: 63 start-page: 298 year: 2008 ident: 10.1093/annonc/mdr587_bb0015 article-title: Multidimensional preventive home visit programs for community-dwelling older adults: a systematic review and meta-analysis of randomized controlled trials publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/63.3.298 |
| SSID | ssj0006929 |
| Score | 2.5972764 |
| Snippet | Development of a geriatric screening tool is necessary to identify elderly cancer patients who would benefit from comprehensive geriatric assessment (CGA). We... BACKGROUNDDevelopment of a geriatric screening tool is necessary to identify elderly cancer patients who would benefit from comprehensive geriatric assessment... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2166 |
| SubjectTerms | Age Factors Aged Aged, 80 and over Antineoplastic agents Biological and medical sciences cancer Early Detection of Cancer - methods elderly Female Geriatric Assessment - methods Humans Male Medical sciences Neoplasms - diagnosis Pharmacology. Drug treatments screening sensitivity and specificity |
| Title | Screening older cancer patients: first evaluation of the G-8 geriatric screening tool |
| URI | https://dx.doi.org/10.1093/annonc/mdr587 https://www.ncbi.nlm.nih.gov/pubmed/22250183 https://www.proquest.com/docview/1030075353 https://www.proquest.com/docview/2351522686 |
| Volume | 23 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSAgJIa6jXCYjIV6KmRc7F_OG0MaAdSDRSn2LHMdGk0oytdkD_HqOL0kaWKTBSxpZrp34fLG_Y58LQi-ZSkE15pREUkrCC85IJhUlJeeCGljxS2H9nWenyfGCf1rGy95d0XmXNMUb9etSv5L_kSqUgVytl-w_SLZrFArgHuQLV5AwXK8k42_KWs04u2WbbNtacCn4CbFSnbGbOQN6txXTu7UJ-ECy6Xf7jDZC_3TTNdTU9WqbsPYBlutKDbbgrWePdlmKpls7ova8yKzlz8FG6wxops28XpGv_mB-BeI--yPl10yvrTV9v3Mb9iKsUUfW7kWE6TMRxEY08qvLJWVhzvU-xgFb2WAC9UlY_prZfdQrWVXwtnDzo1zHYaUexNA-_ZIfLU5O8vnhcn4d3YhSYFSWKn_83K3PiXC567rnCpFXoYN93_y-b3yMqdw-lxv4foxPfDKumTiGMr-L7gTVAr_zOLmHrunqPro5C8YTD9Cigwt2cMEeLriFy1vswIJ7sODaYAALBrDgDiy4Awu2YHmIFkeH8_fHJGTVIIqntCFaUMVVYpml5lybmFGhtYjlQaFURJUBpUClEnRzBaq_EWmss1gXaSKlLrWm7BHagVHSjxE2Cr5oJVh54BRtVRSKJUymzEQCaGk5Qa_bEcxVCDlvM5-scm_6wHI_4Lkf8Al61VU_97FWxirSVhx5IIqeAOaAlrG_7A3E1nUQJcBYQWeZoBetHHOYYe2xmax0fbHJbSI-INYsZuN1IgZ6AWgyWTJBux4EfQ-wZFJYOZ9coYen6Fb_XT1DO836Qj8H1tsUew7EvwE9KrGn |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Screening+older+cancer+patients%3A+first+evaluation+of+the+G-8+geriatric+screening+tool&rft.jtitle=Annals+of+oncology&rft.au=Bellera%2C+C+A&rft.au=Rainfray%2C+M&rft.au=Mathoulin-P%C3%A9lissier%2C+S&rft.au=Mertens%2C+C&rft.date=2012-08-01&rft.issn=1569-8041&rft.eissn=1569-8041&rft.volume=23&rft.issue=8&rft.spage=2166&rft_id=info:doi/10.1093%2Fannonc%2Fmdr587&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon |